NVECTOR, INC.

nVector’s next-generation gene therapy technology is poised to enable revolutionary treatments for central nervous systems (CNS) diseases such as Alzheimer’s, Parkinson’s, ALS, and traumatic brain injury. To drive this capability, the company has brought on board Fredric Manfredsson, Ph.D. as Chief Scientific Officer to team with Robert Bowser, Ph.D., nVector’s Chairman of the Board. Together they are directing the development of nVector’s Adeno-Associated Virus platform, which featu... res the first technology to target brain glia (immune) and neuron cells by type and offers better distribution throughout the spinal cord and brain from a single injection. The combination of nVector’s AAV platform and biomarker assays, including the first biologic diagnostic test for ALS, differentiates nVector from other biotechnology companies in the space.

#SimilarOrganizations #People #Website #More

NVECTOR, INC.

Social Links:

Facebook

Industry:

Biotechnology Genetics Health Care Medical

Founded:

2022-01-01

Address:

Phoenix, Arizona, United States

Country:

United States

Website Url:

http://www.nvector.com

Total Employee:

Status:

Active

Contact:

+1 602 622 1490

Email Addresses:

[email protected]

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics